首页> 外文期刊>ScientificWorldJournal >Long-Term Results of Reconstruction with Pelvic Allografts after Wide Resection of Pelvic Sarcomas
【24h】

Long-Term Results of Reconstruction with Pelvic Allografts after Wide Resection of Pelvic Sarcomas

机译:骨盆肉瘤广泛切除后与盆腔同种异体移植重建的长期结果

获取原文
           

摘要

Reconstruction after the resection of a pelvic tumor is a challenging procedure in orthopedic oncology. The main advantage of allograft reconstruction is restoration of the bony architecture of the complex pelvic region. However, high complication rates such as infection and allograft resorption had been reported in the literature. In this study, we aimed to retrospectively review nine patients treated with pelvic resection and structural pelvic allograft reconstruction. Functional results, complications, and survival of the patients and the allografts were evaluated. At a mean follow-up of 79 months, three patients were dead. Major complications were detected in eight of the nine patients. Infection (four of the nine patients) and allograft resorption (three of the nine patients) were the most common causes of failure. The cumulative survival of the patients was 66.7 percent at 70 months. However, allograft survival was only 26.7 percent at 60 months. Mean MSTS score was 69. In conclusion, we suggest that other reconstruction options should be preferred after pelvic resections because of the high complication rates associated with massive allograft reconstruction.
机译:切除盆腔肿瘤后重建是骨科肿瘤学的挑战程序。同种异体移植重建的主要优点是恢复复杂骨盆区域的骨架结构。然而,在文献中报道了高复杂性率,例如感染和同种异体移植物吸收。在这项研究中,我们旨在回顾性地审查用盆腔切除和结构盆腔同种异体移植重建治疗的九个患者。评估了患者和同种异体移植物的功能结果,并发症和存活。在平均随访79个月,三名患者死亡。在九名患者中发现了主要并发症。感染(四名患者中的四个)和同种异体移植的吸收(九名患者中的三名)是最常见的失败原因。患者的累积存活率在70个月内为66.7%。然而,同种异体移植存活率在60个月内仅为26.7%。意味着MSTS得分为69.总之,我们建议在盆腔切除后,由于与大规模同种异体移植重建相关的高并发症率,其他重建选项应优选其他重建选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号